Strelchenko Nick, Kukharenko Valeri, Shkumatov Artem, Verlinsky Oleg, Kuliev Anver, Verlinsky Yury
Reproductive Genetics Institute, 2825 North Halsted Street, Chicago, IL 60657, USA.
Reprod Biomed Online. 2006 Jan;12(1):107-11. doi: 10.1016/s1472-6483(10)60988-1.
Somatic cell nuclear transfer (SCNT) provides the basis for the development of patient-specific stem cell lines. Recent progress in SCNT suggested the presence of reprogramming factors in human embryonic stem (hES) cells, although no method is currently available for replacement of nuclei of hES cells by somatic cell nuclei. An original technique has been developed, involving the fusion of different types of somatic cells with hES cells, which allowed a complete replacement of the nuclei of hES cells by nuclei of somatic cells. The resulting 'cybrids' were demonstrated to have the genotype of the donor somatic cells and 'stemness' of the recipient hES cells. However, the colonies isolated from the resulting fusion contained a mixture of these cybrid cells with the cells with the recipient nuclei, as well as hybrid cells containing both donor and recipient nuclei, so future purification will be necessary before the technique can be considered for future practical application.
体细胞核移植(SCNT)为患者特异性干细胞系的发展提供了基础。SCNT的最新进展表明人类胚胎干细胞(hES)中存在重编程因子,尽管目前尚无方法可用体细胞核替代hES细胞的细胞核。已开发出一种原始技术,该技术涉及将不同类型的体细胞与hES细胞融合,从而使hES细胞的细胞核被体细胞的细胞核完全替代。结果表明,所得的“胞质杂种”具有供体体细胞的基因型和受体hES细胞的“干性”。然而,从所得融合体中分离出的集落包含这些胞质杂种细胞与带有受体细胞核的细胞的混合物,以及同时含有供体和受体细胞核的杂交细胞,因此在该技术可考虑用于未来实际应用之前,未来还需要进行纯化。